KPIs & Operating Metrics(New)
Growth Metrics

Xylem (XYL) EPS (Weighted Average and Diluted) (2016 - 2025)

Xylem (XYL) has 16 years of EPS (Weighted Average and Diluted) data on record, last reported at $1.37 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 3.01% year-over-year to $1.37; the TTM value through Dec 2025 reached $3.92, up 7.4%, while the annual FY2025 figure was $3.92, 7.4% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $1.37 in Q4 2025 per XYL's latest filing, up from $0.93 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.37 in Q4 2025 and bottomed at $0.07 in Q3 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.73, with a median of $0.63 recorded in 2021.
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 88.89% in 2022, then surged 800.0% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.62 in 2021, then soared by 32.26% to $0.82 in 2022, then surged by 41.46% to $1.16 in 2023, then increased by 14.66% to $1.33 in 2024, then increased by 3.01% to $1.37 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $1.37 in Q4 2025, $0.93 in Q3 2025, and $0.93 in Q2 2025.